Rondo AG Merges US-subsidiary Rondo-Pak with CGS
News Dec 04, 2015
Rondo AG from the Körber Business Area Pharma Systems has signed an agreement with Contemporary Graphics and Bindery, Inc. (CGS) to merge its U.S. subsidiary Rondo-Pak Inc., with the business of CGS. The merged company, named Rondo-Pak, LLC, will offer a comprehensive portfolio of packaging and printed components for customers operating in complex environments, including the pharmaceutical industry.
Both Rondo-Pak and CGS aim to establish this newly combined business in early 2016. With their sites in Norristown, PA and Pennsauken, NJ, respectively, both companies are ideally located in the heart of the U.S. East Coast pharmaceutical corridor. The merger includes all activities of Rondo-Pak and CGS in the U.S., as well as Rondo-Pak’s additional production site in San Juan, Puerto Rico.
The new company will offer a broader variety of products and full service solutions for customers. In particular, the combined technological resources and production capacities will benefit customers in the critical area of supply chain optimization by offering a comprehensive product portfolio and single source supply.
Both companies’ current businesses are, to a significant extent, complementary. The merged business will offer customers of Rondo-Pak an extended range of printed packaging formats such as inserts, leaflets, medication guides and regulated marketing materials. Customers of CGS will have access to Rondo-Pak’s special folding cartons and packaging system expertise, in addition to CGS’ current range of products. Intelligent buying center management and new, innovative products add further value for customers. Existing offerings from both companies will be continued in their current, market-proven exemplary quality standards and according to legal pre-conditions in the regulated pharmaceuticals market.
Clemens Berger, CEO of Körber Medipak Systems AG, Switzerland, says: “We are pleased to join forces with CGS, especially given the company’s highly esteemed position within the industry. The merged business can build on both partners’ longstanding experience in the market, as well as their very positive reputation with our international customer base.”
Joachim Hoeltz, CEO of Rondo AG, Switzerland, adds: “Our U.S. subsidiary Rondo-Pak is gaining a strong strategic partner. We are looking forward to further strengthening and expanding the partnerships with our common global customers as well as to jointly developing new opportunities.”
Tim Moreton, CEO of CGS, states: “We are looking forward to this joint business approach. Adding value for our customers by offering more customized solutions, excellent services and a comprehensive portfolio of printed components is our key aim for the transaction.”
Victor Dixon, President of Rondo-Pak Inc.: “The merger with CGS is a great step forward in realizing our future business growth strategy. We are adding resources and enhancing our production capacities. This clearly enables us to serve our customers even better.”
The businesses of Rondo-Pak in the U.S. and Rondo AG in Switzerland will remain closely linked. The merged business Rondo-Pak, LLC, is set to play a strategic part in serving the global customers of the Körber Medipak Systems network of companies, especially in the healthcare and pharmaceutical sector.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE